Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.42M |
| 2 |
MBIA
MBI
|
+$936K |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
+$443K |
| 4 |
Verizon
VZ
|
+$1.15K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Assured Guaranty
AGO
|
+$5.59M |
| 2 |
BP
BP
|
+$4.35M |
| 3 |
Merck
MRK
|
+$2.6M |
| 4 |
Patterson-UTI
PTEN
|
+$2.46M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.93% |
| 2 | Financials | 34.1% |
| 3 | Energy | 16.56% |
| 4 | Technology | 6.63% |
| 5 | Consumer Staples | 5.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rafael Holdings
RFL
$112M
| $575K | 0.08% |
279,089
-4,358
| -2% | -$8.69K |
|
27
Chevron
CVX
$403B
| $511K | 0.07% |
3,248
| – | – |
|
|
28
Verizon
VZ
$205B
| $495K | 0.07% |
13,335
+31
| +0.2% | +$1.15K |
|
|
NTP
29
DELISTED
Nam Tai Property Inc.
NTP
| $472K | 0.07% |
85,890
-100
| -0.1% | -$550 |
|
30
Navient
NAVI
$886M
| $433K | 0.06% |
23,286
| – | – |
|
31
PepsiCo
PEP
$196B
| $352K | 0.05% |
1,900
| – | – |
|
32
Procter & Gamble
PG
$336B
| $289K | 0.04% |
1,900
| – | – |
|
33
Zedge
ZDGE
$38M
| $264K | 0.04% |
117,785
-2,863
| -2% | -$5.99K |
|
34
Hope Bancorp
HOPE
$1.78B
| $261K | 0.04% |
31,000
| – | – |
|
35
Glacier Bancorp
GBCI
$6.15B
| $180K | 0.03% |
4,320
| – | – |
|
36
AT&T
T
$173B
| $106K | 0.02% |
6,635
| – | – |
|
37
Lifeway Foods
LWAY
$392M
| $65K | 0.01% |
10,000
| – | – |
|
38
Comcast
CMCSA
$95.3B
| $61.3K | 0.01% |
1,476
| – | – |
|
|
IDW
39
DELISTED
IDW Media Holdings
IDW
| $44.2K | 0.01% |
68,016
-1,400
| -2% | -$813 |
|
40
Berkshire Hathaway Class B
BRK.B
$1.06T
| – | – |
-3,107
| Closed | -$959K |
|
41
Provident Financial Services
PFS
$3.09B
| – | – |
-27,472
| Closed | -$527K |
|
Similar funds
Kahn Brothers's Q2 2023 Portfolio in Review
As of Q2 2023, Kahn Brothers held 45 positions worth $682M, down 1.8% from $695M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.4%. Kahn Brothers opened no new positions and exited 2, leaving the 45-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 35% a quarter earlier, followed by Financials and Energy.
- Kahn Brothers added most to Pfizer in Q2 2023, an estimated $1.42M increase.
- Kahn Brothers's biggest Q2 2023 reduction was Assured Guaranty, cutting an estimated $5.59M.
- Kahn Brothers fully exited Berkshire Hathaway Class B in Q2 2023, selling an estimated $959K.
- Kahn Brothers's ten largest holdings make up 82% of its $682M portfolio in Q2 2023.
- Kahn Brothers opened 0 new positions and closed 2 in Q2 2023.
- Kahn Brothers's portfolio value fell 1.8% quarter-over-quarter to $682M.
Based on Kahn Brothers Group's 13F filing for Q2 2023, filed 9 Aug 2023.